Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Maher M. Haddad

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI profile picture
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox (-203 properties)
Infobox
Patent primary examiner of
‌
US Patent 7118905 Nucleic acid encoding angiogenesis inhibitor
‌
US Patent 7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L
‌
US Patent 7129052 Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins
‌
US Patent 11174309 Anti-ANG2 antibody
‌
US Patent 7148063 Mitochondrial creatine kinase antibody
‌
US Patent 7150871 Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6
‌
US Patent 7160541 Modified polypeptides stabilized in a desired conformation and methods for producing same
‌
US Patent 7163681 Anti-integrin antibodies, compositions, methods and uses
‌
US Patent 7169387 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
‌
US Patent 7169566 Metalloproteinases
‌
US Patent 7175849 Nectin polypeptides
‌
US Patent 7186527 Goodpasture antigen binding protein
‌
US Patent 7189517 Goodpasture antigen binding protein
‌
US Patent 7192589 Treatment of inflammatory disorders with STIgMA immunoadhesins
‌
US Patent 7198917 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
‌
US Patent 7202056 Polynucleotides encoding a human cell surface protein with immunoglobulin folds, BGS-19
‌
US Patent 7205113 Methods of modulation of the immune system
‌
US Patent 7208151 Tweak receptor agonists as anti-angiogenic agents
‌
US Patent 7211252 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
‌
US Patent 7211396 Antibody pairs and kits for immunochemical determination of mannan-binding lectin
‌
US Patent 7211400 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
‌
US Patent 7223395 Blocking leukocyte emigration and inflammation by interfering with CD99/HEC2
‌
US Patent 7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same
‌
US Patent 7241873 Recombinant anti-osteopontin antibody and use thereof
‌
US Patent 7244576 Modulators of angiogenesis
‌
US Patent 7252956 Antibodies to human Ependymin
‌
US Patent 7256001 Reagent for determining laminin 5 antigen in biological sample and assay method
‌
US Patent 7261896 Methods for preventing strokes by inducing tolerance to e-selectin
‌
US Patent 7267960 Antagonists and agonists of LDCAM and methods of use
‌
US Patent 7273609 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L
‌
US Patent 7273726 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
‌
US Patent 7276341 Methods and reagents for diagnosis of autoantibodies
‌
US Patent 7276585 Immunoglobulin variants outside the Fc region
‌
US Patent 7282556 Polynucleotides and polypeptides relating to the modulation of SIRPα-CD47
‌
US Patent 7282565 PRO362 polypeptides
‌
US Patent 7285277 Anticancer agent
‌
US Patent 7288390 Anti-dual integrin antibodies, compositions, methods and uses
‌
US Patent 7291475 Methods of expressing integrin β
‌
US Patent 7297775 Polypeptide variants
‌
US Patent 7314615 IκB Kinase-β (IKKβ) binding antibodies and methods of using same
‌
US Patent 7317087 Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof
‌
US Patent 7323311 Methods of obtaining a specific binding member that binds eotaxin
‌
US Patent 7323552 Variant integrin polypeptides and uses thereof
‌
US Patent 7329512 Allergenic latex protein
‌
US Patent 7332162 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders
‌
US Patent 7332581 Polypeptide variants with altered effector function
‌
US Patent 7335742 Polypeptide variants with altered effector function
‌
US Patent 7342106 Human antihuman MCP-1 antibody and antibody fragment thereof
‌
US Patent 7348002 Inducible ligand for α1β1 integrin and uses
‌
US Patent 7348009 Recombinant allergen with reduced enzymatic activity
‌
US Patent 7351803 CD16A binding proteins and use for the treatment of immune disorders
‌
US Patent 7354577 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof
‌
US Patent 7355008 Identification and engineering of antibodies with variant Fc regions and methods of using same
‌
US Patent 7358054 Antibodies to VLA-1
‌
US Patent 7361463 Muteins of hypoxia inducible factor alpha and methods of use thereof
‌
US Patent 7361740 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
‌
US Patent 7364731 Polypeptide variants
‌
US Patent 7364734 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
‌
US Patent 7364735 Method for diagnosis and treatment of haemophilia A patients with an inhibitor
‌
US Patent 7365154 Peptides antagonistic to an anti-angiogenic antibody and uses therefor
‌
US Patent 7365168 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
‌
US Patent 7371825 Anti-MCP-1 antibodies, compositions, methods and uses
‌
US Patent 7371826 Polypeptide variants with altered effector function
‌
US Patent 7374764 CD33-like protein
‌
US Patent 7378504 Human monoclonal antibodies to Fc gamma receptor I (CD64)
‌
US Patent 7381534 Purified linear epitopes from cashew nuts, nucleic acids encoding therefor, and associated methods
‌
US Patent 7381798 Recombinant antibody recognizing dioxin and gene encoding the antibody
‌
US Patent 7384636 Polypeptide
‌
US Patent 7387776 Human monoclonal antibodies against CD30
‌
US Patent 7387779 Anti-angiogenic proteins and fragments and methods of use thereof
‌
US Patent 7388079 Delivery of pharmaceutical agents via the human insulin receptor
‌
US Patent 7390870 Immune-enhancing peptides
‌
US Patent 7393651 Confluence regulated adhesion molecules useful in modulating vascular permeability
‌
US Patent 7396530 Method of treating granuloma annulare or sarcoid
‌
US Patent 7399597 Epitope identification and modification for reduced allergenic activity in proteins targeted for transgenic expression
‌
US Patent 7405274 Connective tissue growth factor antibodies
‌
US Patent 7405275 Antibodies which bind human CXCR3
‌
US Patent 7416727 Polypeptide variants with altered effector function
‌
US Patent 7425333 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7
‌
US Patent 7425619 FcγRIIB specific antibodies and methods of use thereof
‌
US Patent 7425620 FcγRIIB-specific antibodies and methods of use thereof
‌
US Patent 7432061 Assays for measuring matrix metalloproteinase activities
‌
US Patent 7438908 Anti-human tenascin monoclonal antibody
‌
US Patent 7445886 Macrophage migration inhibitory factor as a marker for cardiovascular risk
‌
US Patent 7445903 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
‌
US Patent 7449302 Therapeutic peptides
‌
US Patent 7452677 Monoclonal antibody capable of binding integrin alpha 10 beta 1
‌
US Patent 7452974 Isolated human squalene synthase and composition thereof
‌
US Patent 7459143 Carrier molecules
‌
US Patent 7462352 Methods of treatng B-cell diseases using humanized anti-CD19 antibodies
‌
US Patent 7462353 Method for the treatment of inflammatory disorders
‌
US Patent 7462696 Human antibodies that have MN binding and cell adhesion-neutralizing activity
‌
US Patent 7465449 Anti-α
‌
US Patent 7468183 Antibody immunization therapy for treatment of atherosclerosis
‌
US Patent 7476509 Compounds and methods for modulating functions of nonclassical cadherins
‌
US Patent 7482009 Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use
‌
US Patent 7485429 Integrin heterodimer and an alpha subunit thereof
‌
US Patent 7488478 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
‌
US Patent 7491389 Modulating angiogenesis
‌
US Patent 7491396 Process for the preparation of hypoallergenic mosaic antigens
‌
US Patent 7514531 Specific binding sites in collagen for integrins and use thereof
‌
US Patent 11185585 Methods and compositions for improving antiangiogenic therapy with anti-integrins
‌
US Patent 7517654 Peptide and a derivative thereof promoting cell adhesion and spreading
‌
US Patent 7517655 Protein capable of deposition onto extracellular matrix
‌
US Patent 7521046 Antibody immunization therapy for treatment of atherosclerosis
‌
US Patent 7521192 EDG: modulators of lymphocyte activation and migration
‌
US Patent 7534605 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
‌
US Patent 7541029 Anti-rhesus D monoclonal antibodies
‌
US Patent 7541149 Monoclonal antibody and assay for detecting PIIINP
‌
US Patent 7541438 Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
‌
US Patent 7544358 Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6
‌
US Patent 7550142 Anti-integrin antibodies, compositions, methods and uses
‌
US Patent 7557190 Optimized proteins that target Ep-CAM
‌
US Patent 7566443 Method for diagnosis of chronic allograft rejection
‌
US Patent 7566456 Allergen vaccine proteins for the treatment and prevention of allergic diseases
‌
US Patent 7566539 Anti-CCR2 antibodies and methods of use therefor
‌
US Patent 7569665 Molecular marker
‌
US Patent 7572591 Construct comprising recognition domain of antibody against von Willebrand factor-specific cleaving enzyme
‌
US Patent 7575872 Antibody against von Willebrand factor cleaving enzyme and assay system using the same
‌
US Patent 7576184 Allergenic proteins of natural rubber latex, their production and use in assays
‌
US Patent 7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
‌
US Patent 7582300 Modulation of gamma delta T cells to regulate airway hyperresponsiveness
‌
US Patent 7582438 EphB receptor-binding peptides
‌
US Patent 7592009 Polypeptide ligands for targeting cartilage and methods of use thereof
‌
US Patent 7595045 Anti-α9 integrin antibody and the use thereof
‌
US Patent 7595052 Composition and method for the prevention and/or the treatment of allergy
‌
US Patent 7595165 Method of measuring activation of effector cells
‌
US Patent 7597887 KIM-1 antagonists and use to modulate immune system
‌
US Patent 7605226 Meltrins
‌
US Patent 7608684 Soluble CD14 antigen
‌
US Patent 7618630 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
‌
US Patent 7618817 Genetically modified human natural killer cell lines
‌
US Patent 7625560 Humanized antibodies that recognize beta amyloid peptide
‌
US Patent 7629128 Methods of identifying respondents to hypoxia inducible factor 1-α inhibitors
‌
US Patent 7629131 Rabbit monoclonal antibodies against mouse/human Id3 proteins
‌
US Patent 7629132 Goodpasture antigen binding protein
‌
US Patent 7632495 Use of soluble fgl2 as an immunosuppressant
‌
US Patent 7632507 Synovial cell protein
‌
US Patent 7638325 Activation and expansion of T-cells using an engineered multivalent signaling platform
‌
US Patent 7638326 Activation and expansion of T-cells using an engineered multivalent signaling platform
‌
US Patent 7648701 Peptide composition as immunogen for the treatment of allergy
‌
US Patent 7655417 VCAM-1 specific monoclonal antibody
‌
US Patent 7655782 Modified mite allergen and pharmaceutical uses thereof
‌
US Patent 7659091 Diagnostic marker
‌
US Patent 7659374 Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity
‌
US Patent 7662375 Use of glucose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
‌
US Patent 7662382 Inducible ligand for α1β1 integrin and uses
‌
US Patent 7662388 Endogenous peptide and active subfragments thereof
‌
US Patent 7662569 Methods of assessing Crohn's disease patient phenotype by I2 serologic response
‌
US Patent 7662925 Optimized Fc variants and methods for their generation
‌
US Patent 7662926 Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
‌
US Patent 7666428 Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity
‌
US Patent 7666429 Nucleic acids encoding a house dust mite allergen
‌
US Patent 7667009 Method for purifying modified major mite allergen
‌
US Patent 7670781 Activation and expansion of T-cells using an agent that provides a primary activation signal and another agent that provides a co-stimulatory signal
‌
US Patent 7670826 Confluence regulated adhesion molecules useful in modulating vascular permeability
‌
US Patent 7708994 Therapy of autoimmune disease in a patient with an inadequate response to a TNF-α inhibitor
‌
US Patent 7713712 Antibodies active against a fusion polypeptide comprising a histidine portion
‌
US Patent 7718178 Allergen formulation
‌
US Patent 7718378 Granulysin and uses thereof
‌
US Patent 7723073 Antibodies to VLA-1
‌
US Patent 7731963 TWEAK receptor agonists as anti-angiogenic agents
‌
US Patent 7731970 Variants of the major allergen Phl p 1 from timothy grass
‌
US Patent 7732566 Allergenic latex protein
‌
US Patent 7732570 Alteration of Fc-fusion protein serum half-lives by mutagenesis
‌
US Patent 7741056 Use of A33 antigens and JAM-IT
‌
US Patent 7741072 Polypeptide variants
‌
US Patent 7741115 Antibodies that bind LDCAM
‌
US Patent 7745140 Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
‌
US Patent 7745144 Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins
‌
US Patent 7749710 Marker for stem cells and its use
‌
US Patent 7781176 Antibodies to HTEEB42 protein
‌
US Patent 7785591 Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
‌
US Patent 7785791 Polypeptide variants with altered effector function
‌
US Patent 7786268 Anti-IP-10 antibodies and methods of use thereof
‌
US Patent 7790858 Polypeptide variants with altered effector function
‌
US Patent 7803374 Targeted atherosclerosis treatment
‌
US Patent 7803558 Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in Schlemm's canal cells
‌
US Patent 7807161 Humanized anti-human osteopontin antibody
‌
US Patent 7807167 Administration of agents for the treatment of inflammation
‌
US Patent 7807382 Methods for inhibiting the binding of endosialin to ligands
‌
US Patent 7807794 Anti-α2 integrin antibodies and their uses
‌
US Patent 7815908 Methods and compositions for treating and preventing disease associated with αVβ5 integrin
‌
US Patent 7820172 Laminin-derived multi-domain peptides
‌
US Patent 7833726 Antibody for assaying ADAMTS13 activity and method for assaying the activity
‌
US Patent 7838000 Inhibition of pathogenic agents including α6β1 integrin receptor or α6β4 integrin receptor at a surface
‌
US Patent 7838635 CD16A binding proteins and use for the treatment of immune disorders
‌
US Patent 7842464 Use of ADAM 12 for diagnosis and therapy of preeclampsia
‌
US Patent 7846448 DNA sequence, and recombinant preparation of the grass pollen allergen Lol p4
‌
US Patent 7846449 Modified mite allergen and pharmaceutical uses thereof
‌
US Patent 7846690 Cloning of honey bee allergen
‌
US Patent 7871782 Specific binding members against synaptophysin
‌
US Patent 7883857 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
‌
US Patent 7892556 Apoptotically active peptides
‌
US Patent 7901678 Medicinal compositions containing Fc receptor γ chain activator
‌
US Patent 7901909 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
‌
US Patent 7910097 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof
‌
US Patent 7910099 Antibodies to VLA-1
‌
US Patent 7927591 Conformation specific antibodies
‌
US Patent 7935492 Goodpasture antigen binding protein and its detection
‌
US Patent 7981619 Composition for prevention, treatment, and diagnosis of chronic obstructive pulmonary disease (COPD)
‌
US Patent 7981672 Monoclonal antibody and use thereof
‌
US Patent 7999069 EphB receptor-binding peptides
Edits on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7999069 EphB receptor-binding peptides
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7981672 Monoclonal antibody and use thereof
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7935492 Goodpasture antigen binding protein and its detection
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7927591 Conformation specific antibodies
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7910099 Antibodies to VLA-1
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7901678 Medicinal compositions containing Fc receptor γ chain activator
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7892556 Apoptotically active peptides
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7871782 Specific binding members against synaptophysin
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7846690 Cloning of honey bee allergen
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7846449 Modified mite allergen and pharmaceutical uses thereof
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7846448 DNA sequence, and recombinant preparation of the grass pollen allergen Lol p4
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7842464 Use of ADAM 12 for diagnosis and therapy of preeclampsia
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7838635 CD16A binding proteins and use for the treatment of immune disorders
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7833726 Antibody for assaying ADAMTS13 activity and method for assaying the activity

Find more people like Maher M. Haddad

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.